Inspire Medical Systems, Inc.

DB:2DR Stock Report

Market Cap: €4.9b

Inspire Medical Systems Past Earnings Performance

Past criteria checks 3/6

Inspire Medical Systems has been growing earnings at an average annual rate of 22.2%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 44.4% per year. Inspire Medical Systems's return on equity is 4.7%, and it has net margins of 4.4%.

Key information

22.2%

Earnings growth rate

24.9%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate44.4%
Return on equity4.7%
Net Margin4.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Inspire Medical Systems makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:2DR Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2475633512115
30 Jun 247066495118
31 Mar 24661-16476120
31 Dec 23625-21452117
30 Sep 23570-33423107
30 Jun 23526-4139599
31 Mar 23466-4435982
31 Dec 22408-4532169
30 Sep 22348-5028558
30 Jun 22301-4425246
31 Mar 22262-4322441
31 Dec 21233-4220337
30 Sep 21201-4718234
30 Jun 21175-4716232
31 Mar 21134-5714129
31 Dec 20115-5712826
30 Sep 2096-5911723
30 Jun 2081-5710719
31 Mar 2087-4110016
31 Dec 1982-339013
30 Sep 1972-297811
30 Jun 1964-25699
31 Mar 1957-24628
31 Dec 1851-22547
30 Sep 1844-21487
30 Jun 1838-21426
31 Mar 1833-20376
31 Dec 1729-18326
31 Dec 1616-19237
31 Dec 158-21187

Quality Earnings: 2DR has high quality earnings.

Growing Profit Margin: 2DR became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 2DR has become profitable over the past 5 years, growing earnings by 22.2% per year.

Accelerating Growth: 2DR has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 2DR has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (21%).


Return on Equity

High ROE: 2DR's Return on Equity (4.7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies